Inventor
Nadav BLEICH KIMELMAN
Inventor
IL
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes36%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
C07KPeptides14%
C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds9%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
PatentTitleYear
12,514,908Semaglutide depot systems and use thereof202612,370,233Depot systems comprising glatiramer acetate202512,343,371Method for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using a sustained release depot formulation comprising glatiramer acetate202512,161,688Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells202412,097,292Process for preparing microparticles containing glatiramer acetate202411,865,213Semaglutide depot systems and use thereof202411,471,421Process for preparing microparticles containing glatiramer acetate202211,413,311Treatment of multiple sclerosis with long acting glatiramer and adipose-derived stem cells2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to MAPI PHARMA LTD (8)· patent assignee history
2022–2024Patents assigned to STEM CELL MEDICINE LTD (2)· patent assignee history
2022–2026Based in IL· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MAPI PHARMA LTD | 8 | 2022–2026 |
| STEM CELL MEDICINE LTD | 2 | 2022–2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| IL | 8 | 2022–2026 |